The risk or severity of adverse effects can be increased when pentazocine is combined with rasagiline.


The risk or severity of adverse effects can be increased when loxapine is combined with gabapentin.


The risk or severity of adverse effects can be increased when tolterodine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when pergolide is combined with danazol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Nebivolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with paramethasone.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Pramocaine.


The risk or severity of adverse effects can be increased when temazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with tretinoin.


The risk or severity of adverse effects can be increased when nimodipine is combined with indapamide.


The risk or severity of adverse effects can be increased when fosinopril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when dibucaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when nicergoline is combined with nifedipine.


The risk or severity of adverse effects can be increased when nicergoline is combined with miconazole.


The risk or severity of adverse effects can be increased when meprobamate is combined with clidinium.


The risk or severity of adverse effects can be increased when clorazepate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when meprobamate is combined with benzocaine.


The risk or severity of adverse effects can be increased when Trospium is combined with Vecuronium.


The risk or severity of adverse effects can be increased when prazosin is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when mecamylamine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Trospium is combined with pancuronium.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when olanzapine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Perospirone is combined with triprolidine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when scopolamine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Perospirone is combined with methylphenidate.


The risk or severity of adverse effects can be increased when Perospirone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Normethadone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when butabarbital is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when oxazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when methscopolamine is combined with meperidine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with ramipril.


The risk or severity of adverse effects can be increased when chlormezanone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with valsartan.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with etodolac.


The risk or severity of adverse effects can be increased when efavirenz is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when amiodarone is combined with ramipril.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with brotizolam.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with paromomycin.


The risk or severity of adverse effects can be increased when Tramadol is combined with Alvimopan.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Etomidate is combined with zotepine.


The risk or severity of adverse effects can be increased when Etomidate is combined with MELPERONE.


The risk or severity of adverse effects can be increased when thioridazine is combined with benazepril.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with losartan.


The risk or severity of adverse effects can be increased when benazepril is combined with indapamide.


The risk or severity of adverse effects can be increased when thiopental is combined with tizanidine.


The risk or severity of adverse effects can be increased when difluprednate is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when furosemide is combined with Epirubicin.


The risk or severity of adverse effects can be increased when betamethasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when diltiazem is combined with Aliskiren.


The risk or severity of adverse effects can be increased when pergolide is combined with tetracycline.


The risk or severity of adverse effects can be increased when tetracaine is combined with loratadine.


The risk or severity of adverse effects can be increased when tetracaine is combined with imipramine.


The risk or severity of adverse effects can be increased when codeine is combined with theobromine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with clofazimine.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with plicamycin.


The risk or severity of adverse effects can be increased when fenoprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when Bivalirudin is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when sulpiride is combined with trimipramine.


The risk or severity of adverse effects can be increased when isoproterenol is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when sulpiride is combined with procaine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when halothane is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Tolcapone is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Asenapine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when tiagabine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with dantrolene.


The risk or severity of adverse effects can be increased when dibucaine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with tiagabine.


The risk or severity of adverse effects can be increased when furosemide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with pentostatin.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with zonisamide.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when chloroxine is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with benazepril.


The risk or severity of adverse effects can be increased when flunisolide is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when nystatin is combined with Amrinone.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when tropicamide is combined with Mirabegron.


The risk or severity of adverse effects can be increased when oxprenolol is combined with prazepam.


The risk or severity of adverse effects can be increased when selegiline is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with bifonazole.


The risk or severity of adverse effects can be increased when propoxyphene is combined with tizanidine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when selegiline is combined with thiothixene.


The risk or severity of adverse effects can be increased when selegiline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with duloxetine.


The risk or severity of adverse effects can be increased when codeine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with fluoxetine.


The risk or severity of adverse effects can be increased when rasagiline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when dipyridamole is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when butabarbital is combined with risperidone.


The risk or severity of adverse effects can be increased when butabarbital is combined with meclizine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when meprobamate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Pipazethate is combined with mecamylamine.


The risk or severity of adverse effects can be increased when isradipine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Olmesartan is combined with diltiazem.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Tolcapone.


The risk or severity of adverse effects can be increased when triazolam is combined with tetracaine.


The risk or severity of adverse effects can be increased when THYMOL is combined with nicardipine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Lurasidone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with enflurane.


The risk or severity of adverse effects can be increased when Tapentadol is combined with moclobemide.


The risk or severity of adverse effects can be increased when bepridil is combined with sevoflurane.


The risk or severity of adverse effects can be increased when chlormezanone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when sotalol is combined with Riociguat.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with butorphanol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when thiothixene is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Tapentadol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Tapentadol is combined with bumetanide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Remoxipride.


The risk or severity of adverse effects can be increased when oxprenolol is combined with nicotine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when oxprenolol is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when epoprostenol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with baclofen.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Halazepam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when ketoprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when methyldopa is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with proparacaine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when quazepam is combined with butamben.


The risk or severity of adverse effects can be increased when propoxyphene is combined with indapamide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with lisinopril.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Lurasidone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with butamben.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Naftifine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Melatonin is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with baclofen.


The risk or severity of adverse effects can be increased when butorphanol is combined with amoxapine.


The risk or severity of adverse effects can be increased when butorphanol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when butalbital is combined with trimipramine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with rasagiline.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Retigabine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with periciazine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with quinapril.


The risk or severity of adverse effects can be increased when lidocaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with glutethimide.


The risk or severity of adverse effects can be increased when meperidine is combined with dyclonine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when tolazoline is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when quazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with loratadine.


The risk or severity of adverse effects can be increased when tropicamide is combined with nalbuphine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with imipramine.


The risk or severity of adverse effects can be increased when indomethacin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when resveratrol is combined with flunisolide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with proparacaine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when oxazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when buspirone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when antipyrine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when rizatriptan is combined with thiothixene.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Flibanserin.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with diflorasone.


The risk or severity of adverse effects can be increased when brimonidine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when tiagabine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when propofol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Arotinolol is combined with metolazone.


The risk or severity of adverse effects can be increased when olanzapine is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with sotalol.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when olanzapine is combined with loxapine.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with metoclopramide.


The risk or severity of adverse effects can be increased when minoxidil is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when minoxidil is combined with metolazone.


The risk or severity of adverse effects can be increased when methysergide is combined with astemizole.


The risk or severity of adverse effects can be increased when valsartan is combined with Droxicam.


The risk or severity of adverse effects can be increased when valsartan is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when risperidone is combined with Perospirone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with halcinonide.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with levodopa.


The risk or severity of adverse effects can be increased when promethazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with dantrolene.


The risk or severity of adverse effects can be increased when tolmetin is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when sulindac is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when loratadine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when zonisamide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with buspirone.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with oxycodone.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with codeine.


The risk or severity of adverse effects can be increased when Micafungin is combined with nifedipine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Torasemide.


The risk or severity of adverse effects can be increased when methysergide is combined with Voriconazole.


The risk or severity of adverse effects can be increased when Telmisartan is combined with azelastine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with primidone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with bupropion.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Escitalopram.


The risk or severity of adverse effects can be increased when methysergide is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Spirapril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when methysergide is combined with SAQUINAVIR.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Voriconazole is combined with toremifene.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Regorafenib.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with clidinium.


The risk or severity of adverse effects can be increased when amcinonide is combined with enoxacin.


The risk or severity of adverse effects can be increased when triprolidine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Droxicam is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when benztropine is combined with Normethadone.


The risk or severity of adverse effects can be increased when proparacaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with potassium ion.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when methadone is combined with Asenapine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when suprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when levorphanol is combined with brotizolam.


The risk or severity of adverse effects can be increased when Remoxipride is combined with HEROIN.


The risk or severity of adverse effects can be increased when Articaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when doxazosin is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when nimodipine is combined with fosinopril.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with desoximetasone.


The risk or severity of adverse effects can be increased when ipratropium is combined with trihexyphenidyl.


The risk or severity of adverse effects can be increased when docetaxel is combined with mechlorethamine.


The risk or severity of adverse effects can be increased when Micafungin is combined with barnidipine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Halazepam.


The risk or severity of adverse effects can be increased when thioridazine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when zaleplon is combined with Pipamperone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when quinapril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when fosinopril is combined with carprofen.


The risk or severity of adverse effects can be increased when methylergonovine is combined with cisapride.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with hydralazine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with amoxapine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when butorphanol is combined with tiapride.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when oxaprozin is combined with flumethasone.


The risk or severity of adverse effects can be increased when amifostine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with epirizole.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when butalbital is combined with doxepin.


The risk or severity of adverse effects can be increased when flurazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when clopidogrel is combined with Apixaban.


The risk or severity of adverse effects can be increased when risperidone is combined with Halazepam.


The risk or severity of adverse effects can be increased when risperidone is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when valsartan is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when apomorphine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with leflunomide.


The risk or severity of adverse effects can be increased when quinapril is combined with cilazapril.


The risk or severity of adverse effects can be increased when reserpine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tioconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when pargyline is combined with oxycodone.


The risk or severity of adverse effects can be increased when pargyline is combined with buspirone.


The risk or severity of adverse effects can be increased when tioconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Olopatadine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with dobutamine.


The risk or severity of adverse effects can be increased when tioconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with fenoldopam.


The risk or severity of adverse effects can be increased when metolazone is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with salicylamide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when epinastine is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when metoclopramide is combined with amitriptyline.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with tetracaine.


The risk or severity of adverse effects can be increased when promazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when butamben is combined with scopolamine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with triamterene.


The risk or severity of adverse effects can be increased when rapamycin is combined with nifedipine.


The risk or severity of adverse effects can be increased when HEROIN is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when HEROIN is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when phenylephrine is combined with ritodrine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when proparacaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when cabergoline is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Articaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when valsartan is combined with epirizole.


The risk or severity of adverse effects can be increased when terconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Tiotropium is combined with Normethadone.


The risk or severity of adverse effects can be increased when ibuprofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when rivastigmine is combined with acetylcholine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Paliperidone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when cetirizine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when chloroquine is combined with prilocaine.


The risk or severity of adverse effects can be increased when Netupitant is combined with oxycodone.


The risk or severity of adverse effects can be increased when morphine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when morphine is combined with lisinopril.


The risk or severity of adverse effects can be increased when morphine is combined with procaine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with propofol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with epirizole.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with papaverine.


The risk or severity of adverse effects can be increased when triazolam is combined with felbamate.


The risk or severity of adverse effects can be increased when pentazocine is combined with Asenapine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Almotriptan.


The risk or severity of adverse effects can be increased when fenoprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with difluprednate.


The risk or severity of adverse effects can be increased when enalapril is combined with nicardipine.


The risk or severity of adverse effects can be increased when tiapride is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with halcinonide.


The risk or severity of adverse effects can be increased when papaverine is combined with Bretylium.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Amrinone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when pergolide is combined with olanzapine.


The risk or severity of adverse effects can be increased when triprolidine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Normethadone is combined with rasagiline.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when trandolapril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when amoxapine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when betamethasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Echothiophate.


The risk or severity of adverse effects can be increased when amoxapine is combined with moclobemide.


The risk or severity of adverse effects can be increased when epirizole is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when thiothixene is combined with imipramine.


The risk or severity of adverse effects can be increased when prednisone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Olsalazine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when thiothixene is combined with loratadine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with etizolam.


The risk or severity of adverse effects can be increased when mesoridazine is combined with protriptyline.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when fluocinonide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Efonidipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with bromazepam.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Eplerenone.


The risk or severity of adverse effects can be increased when docetaxel is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with doxepin.


The risk or severity of adverse effects can be increased when fenoldopam is combined with methazolamide.


The risk or severity of adverse effects can be increased when fenoldopam is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when fenoldopam is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Talniflumate is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when Butethal is combined with paroxetine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Bretylium.


The risk or severity of adverse effects can be increased when butorphanol is combined with mesoridazine.


The risk or severity of adverse effects can be increased when trazodone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when carprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when trandolapril is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when butabarbital is combined with dyclonine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with felbamate.


The risk or severity of adverse effects can be increased when Etomidate is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when spironolactone is combined with Bretylium.


The risk or severity of adverse effects can be increased when Naftifine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when fludiazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with clonidine.


The risk or severity of adverse effects can be increased when propofol is combined with tiagabine.


The risk or severity of adverse effects can be increased when propofol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Vilazodone is combined with lithium ion.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when chloroquine is combined with etodolac.


The risk or severity of adverse effects can be increased when BENZNIDAZOLE is combined with leflunomide.


The risk or severity of adverse effects can be increased when butabarbital is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when diclofenac is combined with chloroquine.


The risk or severity of adverse effects can be increased when imipramine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when metoprolol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with difluprednate.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with halcinonide.


The risk or severity of adverse effects can be increased when Pramocaine is combined with clidinium.


The risk or severity of adverse effects can be increased when Milnacipran is combined with dicumarol.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when ropinirole is combined with papaverine.


The risk or severity of adverse effects can be increased when zaleplon is combined with clidinium.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Ifenprodil.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when clonidine is combined with nifedipine.


The risk or severity of adverse effects can be increased when clonidine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when clonidine is combined with papaverine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with indapamide.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Nabilone is combined with betaxolol.


The risk or severity of adverse effects can be increased when codeine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Difenoxin is combined with venlafaxine.


The risk or severity of adverse effects can be increased when terbutaline is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when doxycycline is combined with dapsone.


The risk or severity of adverse effects can be increased when loxapine is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when secobarbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when procaine is combined with cocaine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with antipyrine.


The risk or severity of adverse effects can be increased when procaine is combined with ondansetron.


The risk or severity of adverse effects can be increased when ondansetron is combined with HEROIN.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when cabergoline is combined with MELPERONE.


The risk or severity of adverse effects can be increased when cabergoline is combined with zotepine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with oxprenolol.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with amcinonide.


The risk or severity of adverse effects can be increased when apomorphine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when thiamylal is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Torasemide.


The risk or severity of adverse effects can be increased when protriptyline is combined with Desloratadine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when secobarbital is combined with zaleplon.


The risk or severity of adverse effects can be increased when secobarbital is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Artemether is combined with manidipine.


The risk or severity of adverse effects can be increased when benzocaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when pentazocine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when pirenzepine is combined with quinidine.


The risk or severity of adverse effects can be increased when morniflumate is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when spironolactone is combined with irbesartan.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with sotalol.


The risk or severity of adverse effects can be increased when trandolapril is combined with propranolol.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with enflurane.


The risk or severity of adverse effects can be increased when spironolactone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when sertraline is combined with amisulpride.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Icatibant.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Decitabine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Sunitinib.


The risk or severity of adverse effects can be increased when mepivacaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with sertraline.


The risk or severity of adverse effects can be increased when Torasemide is combined with doxorubicin.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Milnacipran.


The risk or severity of adverse effects can be increased when oxazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with budesonide.


The risk or severity of adverse effects can be increased when maprotiline is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with tiapride.


The risk or severity of adverse effects can be increased when Pramocaine is combined with butamben.


The risk or severity of adverse effects can be increased when triazolam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when triazolam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Halazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when meperidine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when secobarbital is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when loxapine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when midazolam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when pergolide is combined with thiopental.


The risk or severity of adverse effects can be increased when dicyclomine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Pizotifen is combined with sertraline.


The risk or severity of adverse effects can be increased when bumetanide is combined with Bretylium.


The risk or severity of adverse effects can be increased when nicergoline is combined with anastrozole.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when nicergoline is combined with clarithromycin.


The risk or severity of adverse effects can be increased when Halazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when Halazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when meclizine is combined with tiagabine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Halazepam.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when sotalol is combined with papaverine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with floctafenine.


The risk or severity of adverse effects can be increased when doxepin is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Lacidipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when temazepam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Halazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when Conivaptan is combined with D-mannitol.


The risk or severity of adverse effects can be increased when lorazepam is combined with meperidine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with leflunomide.


The risk or severity of adverse effects can be increased when Halazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when ropinirole is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when ATROPINE is combined with morphine.


The risk or severity of adverse effects can be increased when cilostazol is combined with Apixaban.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when etizolam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when temazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when amisulpride is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with mesalamine.


The risk or severity of adverse effects can be increased when tizanidine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with furazolidone.


The risk or severity of adverse effects can be increased when ondansetron is combined with carisoprodol.


The risk or severity of adverse effects can be increased when isoflurane is combined with enflurane.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Demecarium is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Demecarium is combined with nicotine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when propofol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when propofol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when propofol is combined with doxazosin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when metoprolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when propofol is combined with labetalol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with butalbital.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with prazosin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Escitalopram is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with benzocaine.


The risk or severity of adverse effects can be increased when ramipril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Melatonin.


The risk or severity of adverse effects can be increased when medrysone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Dothiepin is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when oxprenolol is combined with cetirizine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with epirizole.


The risk or severity of adverse effects can be increased when gabapentin is combined with mesoridazine.


The risk or severity of adverse effects can be increased when gabapentin is combined with maprotiline.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with enflurane.


The risk or severity of adverse effects can be increased when prazosin is combined with enalapril.


The risk or severity of adverse effects can be increased when fluocinonide is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when loxapine is combined with quetiapine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with doxepin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when buspirone is combined with sumatriptan.


The risk or severity of adverse effects can be increased when Tramadol is combined with codeine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Alvimopan.


The risk or severity of adverse effects can be increased when buspirone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Tramadol is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with pimozide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when butalbital is combined with primidone.


The risk or severity of adverse effects can be increased when Nebivolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with desipramine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when ipratropium is combined with HEROIN.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with floctafenine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Etomidate is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when ropinirole is combined with methazolamide.


The risk or severity of adverse effects can be increased when Articaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when oxycodone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when oxycodone is combined with zaleplon.


The risk or severity of adverse effects can be increased when etodolac is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Torasemide is combined with Arbekacin.


The risk or severity of adverse effects can be increased when Salsalate is combined with difluprednate.


The risk or severity of adverse effects can be increased when benazepril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Salsalate is combined with halcinonide.


The risk or severity of adverse effects can be increased when celecoxib is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when phentolamine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with doxepin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with niflumic acid.


The risk or severity of adverse effects can be increased when selegiline is combined with perphenazine.


The risk or severity of adverse effects can be increased when nabumetone is combined with halcinonide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when amisulpride is combined with Tolcapone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with maprotiline.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with mesalamine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when perphenazine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when brotizolam is combined with loratadine.


The risk or severity of adverse effects can be increased when benzphetamine is combined with dopamine.


The risk or severity of adverse effects can be increased when ondansetron is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when dyclonine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when dyclonine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with pimozide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when brotizolam is combined with imipramine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with terazosin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with tizanidine.


The risk or severity of adverse effects can be increased when codeine is combined with estazolam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Droxicam is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with meclizine.


The risk or severity of adverse effects can be increased when apomorphine is combined with cilazapril.


The risk or severity of adverse effects can be increased when desipramine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with brotizolam.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with epoprostenol.


The risk or severity of adverse effects can be increased when perphenazine is combined with triazolam.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when triamcinolone is combined with enoxacin.


The risk or severity of adverse effects can be increased when Rotigotine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when itraconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when bromazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when bromazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with amisulpride.


The risk or severity of adverse effects can be increased when Melatonin is combined with felbamate.


The risk or severity of adverse effects can be increased when Tramadol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with midazolam.


The risk or severity of adverse effects can be increased when Tramadol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with vinblastine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Tramadol is combined with oxymorphone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with codeine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Tramadol is combined with zopiclone.


The risk or severity of adverse effects can be increased when barnidipine is combined with fosinopril.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when enflurane is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when halothane is combined with timolol.


The risk or severity of adverse effects can be increased when Torasemide is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with promethazine.


The risk or severity of adverse effects can be increased when Torasemide is combined with tizanidine.


The risk or severity of adverse effects can be increased when Torasemide is combined with furosemide.


The risk or severity of adverse effects can be increased when tolterodine is combined with codeine.


The risk or severity of adverse effects can be increased when methysergide is combined with hydralazine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with moclobemide.


The risk or severity of adverse effects can be increased when paroxetine is combined with zotepine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Treprostinil is combined with fenoprofen.


The risk or severity of adverse effects can be increased when carprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with terbutaline.


The risk or severity of adverse effects can be increased when Halazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with doxepin.


The risk or severity of adverse effects can be increased when cabergoline is combined with maprotiline.


The risk or severity of adverse effects can be increased when demeclocycline is combined with tretinoin.


The risk or severity of adverse effects can be increased when amobarbital is combined with lithium ion.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Lurasidone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with benzocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Torasemide is combined with metolazone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with fosinopril.


The risk or severity of adverse effects can be increased when Torasemide is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when nicergoline is combined with modafinil.


The risk or severity of adverse effects can be increased when Posaconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when brotizolam is combined with zotepine.


The risk or severity of adverse effects can be increased when brotizolam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when clorazepate is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Clevidipine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with spironolactone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with bromazepam.


The risk or severity of adverse effects can be increased when bumetanide is combined with Riociguat.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when thiopental is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Naftifine is combined with equilin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with HEROIN.


The risk or severity of adverse effects can be increased when cabergoline is combined with metyrapone.


The risk or severity of adverse effects can be increased when cabergoline is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when temazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when cabergoline is combined with glyburide.


The risk or severity of adverse effects can be increased when levorphanol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when zopiclone is combined with HEROIN.


The risk or severity of adverse effects can be increased when levorphanol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when propofol is combined with rasagiline.


The risk or severity of adverse effects can be increased when butamben is combined with baclofen.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with amisulpride.


The risk or severity of adverse effects can be increased when methadone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when lisinopril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when felbamate is combined with flunarizine.


The risk or severity of adverse effects can be increased when lisinopril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when tetracaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when proparacaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when tubocurarine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when Naftifine is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when ethopropazine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when quazepam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Desloratadine.


The risk or severity of adverse effects can be increased when quazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Desloratadine.


The risk or severity of adverse effects can be increased when butabarbital is combined with oxprenolol.


The risk or severity of adverse effects can be increased when rasagiline is combined with terazosin.


The risk or severity of adverse effects can be increased when morphine is combined with dibucaine.


The risk or severity of adverse effects can be increased when morphine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when zonisamide is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Naftifine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with dipivefrin.


The risk or severity of adverse effects can be increased when mepivacaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when trazodone is combined with brotizolam.


The risk or severity of adverse effects can be increased when thioridazine is combined with meclizine.


The risk or severity of adverse effects can be increased when benzocaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Etomidate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when ibuprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when Halazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when 3,4-Dihydroxybenzaldehyde is combined with Nintedanib.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Paliperidone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when cabergoline is combined with bifonazole.


The risk or severity of adverse effects can be increased when celecoxib is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when furosemide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when enalapril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Flupentixol is combined with pimozide.


The risk or severity of adverse effects can be increased when pimozide is combined with Etomidate.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with memantine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when morphine is combined with Perospirone.


The risk or severity of adverse effects can be increased when pimozide is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when pimozide is combined with bupivacaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Etomidate.


The risk or severity of adverse effects can be increased when propofol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when thiothixene is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with bupivacaine.


The risk or severity of adverse effects can be increased when temazepam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when nimesulide is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Tolcapone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when epirizole is combined with Droxicam.


The risk or severity of adverse effects can be increased when imipramine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when zopiclone is combined with duloxetine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Ditazole.


The risk or severity of adverse effects can be increased when zopiclone is combined with fluoxetine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with fluvastatin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when clozapine is combined with Normethadone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Eplerenone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with methazolamide.


The risk or severity of adverse effects can be increased when Talniflumate is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with tiagabine.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when fludiazepam is combined with butamben.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when ethanol is combined with didanosine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Lurasidone.


The risk or severity of adverse effects can be increased when reserpine is combined with pimozide.


The risk or severity of adverse effects can be increased when olanzapine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with clomipramine.


The risk or severity of adverse effects can be increased when IMIQUIMOD is combined with leflunomide.


The risk or severity of adverse effects can be increased when zonisamide is combined with citalopram.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Telmisartan is combined with celecoxib.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with galanthamine.


The risk or severity of adverse effects can be increased when atenolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when imipramine is combined with terazosin.


The risk or severity of adverse effects can be increased when promazine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when promethazine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when vigabatrin is combined with flunarizine.


The risk or severity of adverse effects can be increased when promazine is combined with flurazepam.


The risk or severity of adverse effects can be increased when Naftifine is combined with etodolac.


The risk or severity of adverse effects can be increased when fenbufen is combined with difluprednate.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when methadone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Naftifine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Pramocaine is combined with clonidine.


The risk or severity of adverse effects can be increased when Naftifine is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when nicardipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when methysergide is combined with Atomoxetine.


The risk or severity of adverse effects can be increased when lisinopril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when suprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when carprofen is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when methysergide is combined with clemastine.


The risk or severity of adverse effects can be increased when SULFALENE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Agomelatine.


The risk or severity of adverse effects can be increased when brimonidine is combined with nefazodone.


The risk or severity of adverse effects can be increased when Melatonin is combined with desipramine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Asenapine.


The risk or severity of adverse effects can be increased when midazolam is combined with zaleplon.


The risk or severity of adverse effects can be increased when Melatonin is combined with thiamylal.


The risk or severity of adverse effects can be increased when Olmesartan is combined with etodolac.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Melatonin is combined with halothane.


The risk or severity of adverse effects can be increased when primidone is combined with duloxetine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with bromazepam.


The risk or severity of adverse effects can be increased when primidone is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with irinotecan.


The risk or severity of adverse effects can be increased when naratriptan is combined with metoclopramide.


The risk or severity of adverse effects can be increased when nortriptyline is combined with ritodrine.


The risk or severity of adverse effects can be increased when Nabilone is combined with minoxidil.


The risk or severity of adverse effects can be increased when Remoxipride is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when oxprenolol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with methotrexate.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with HEROIN.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with nalbuphine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with CAPECITABINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Nabilone.


The risk or severity of adverse effects can be increased when fosinopril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Nebivolol.


The risk or severity of adverse effects can be increased when haloperidol is combined with prilocaine.


The risk or severity of adverse effects can be increased when fosinopril is combined with clonidine.


The risk or severity of adverse effects can be increased when Bosutinib is combined with clozapine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with progesterone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with sotalol.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when promethazine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when meperidine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when bromocriptine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when timolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Pipamperone is combined with prazosin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with methyldopa.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Nabilone.


The risk or severity of adverse effects can be increased when flurazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when 6-Mercaptopurine is combined with clozapine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with loratadine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with brimonidine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with alclofenac.


The risk or severity of adverse effects can be increased when lisinopril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when clonidine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when olanzapine is combined with butorphanol.


The risk or severity of adverse effects can be increased when clonidine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Paricalcitol is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when promazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when bepridil is combined with Rotigotine.


The risk or severity of adverse effects can be increased when furazolidone is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when THYMOL is combined with nitrendipine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with methazolamide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when cabergoline is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when tiapride is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when ketamine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when aspirin is combined with nabumetone.


The risk or severity of adverse effects can be increased when lorazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when lorazepam is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Talniflumate is combined with resveratrol.


The risk or severity of adverse effects can be increased when oxazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Propiverine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when chloroquine is combined with fenbufen.


The risk or severity of adverse effects can be increased when methocarbamol is combined with clonidine.


The risk or severity of adverse effects can be increased when donepezil is combined with methacholine.


The risk or severity of adverse effects can be increased when promazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when etizolam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nisoldipine.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when etizolam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nabumetone is combined with tolmetin.


The risk or severity of adverse effects can be increased when nabumetone is combined with haloperidol.


The risk or severity of adverse effects can be increased when naratriptan is combined with thioridazine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when minoxidil is combined with propranolol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when prazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when irbesartan is combined with quinapril.


The risk or severity of adverse effects can be increased when amitriptyline is combined with efavirenz.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ethanol is combined with bupropion.


The risk or severity of adverse effects can be increased when loxapine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when tizanidine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when doxorubicin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Eplerenone.


The risk or severity of adverse effects can be increased when triazolam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when celecoxib is combined with equilin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Clobetasone.


The risk or severity of adverse effects can be increased when diflunisal is combined with prednisone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with ethotoin.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with furosemide.


The risk or severity of adverse effects can be increased when quinidine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when sevoflurane is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when nilvadipine is combined with tretinoin.


The risk or severity of adverse effects can be increased when haloperidol is combined with thiamylal.


The risk or severity of adverse effects can be increased when amobarbital is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when acebutolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when captopril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with deslanoside.


The risk or severity of adverse effects can be increased when leflunomide is combined with acemetacin.


The risk or severity of adverse effects can be increased when Icatibant is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when promazine is combined with bromazepam.


The risk or severity of adverse effects can be increased when promethazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when promethazine is combined with moclobemide.


The risk or severity of adverse effects can be increased when biperiden is combined with tolterodine.


The risk or severity of adverse effects can be increased when etizolam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when propofol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Propiverine is combined with Normethadone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with etizolam.


The risk or severity of adverse effects can be increased when lisinopril is combined with chloroquine.


The risk or severity of adverse effects can be increased when Isavuconazonium is combined with atorvastatin.


The risk or severity of adverse effects can be increased when epinephrine is combined with Ephedrine.